he patent on the tuberculosis drug bedaquiline expired on July 18. But while its manufacturer, Johnson & Johnson, could use secondary patents to extend its exclusive right to sell the drug, it instead struck an
Why a tuberculosis drug will reach millions more patients
Aug 04, 2023
1 minute
You’re reading a preview, subscribe to read more.
Start your free 30 days